Rekha Thiruvengadam

Dr. Rekha Thiruvengadam

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

21 March 2024 in Bioprocess and Biosystems Engineering
Verified
Journal Article
Closed access
PDF file
SKShahid Khan
Shahid Khan
Abdur RaufAbdur Rauf
Abdur Rauf
AAAbdullah S. M. Aljohani
Abdullah S. M. Aljohani
YAYahya S. Al-Awthan
Yahya S. Al-Awthan
ZAZubair Ahmad
Zubair Ahmad
MTMuthu Thiruvengadam
Muthu Thiruvengadam

5 September 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Jin Hee KimJin Hee Kim
Jin Hee Kim
BDBoluwatife Olamide Dareowolabi
Boluwatife Olamide Dareowolabi
RTRekha Thiruvengadam
Rekha Thiruvengadam
EMEun-Yi Moon
Eun-Yi Moon
Cancer is well recognized as a leading cause of mortality. Although surgery tends to be the primary treatment option for many solid cancers, cancer surgery is still a risk factor for metastatic diseases and recurrence. For this reason, a variety of medications has been adopted for the postsurgical care of patients with cancer. However, conventional medicines have shown major challenges such as drug resistance, a high level of drug toxicity, and different drug responses, due to tumor heterogeneity. Nanotechnology-based therapeutic formulations could effectively overcome the challenges faced by conventional treatment methods. In particular, the combined use of nanomedicine with natural phytochemicals can enhance tumor targeting and increase the efficacy of anticancer agents with better solubility and bioavailability and reduced side effects. However, there is limited evidence in relation to the application of phytochemicals in cancer treatment, particularly focusing on nanotechnology. Therefore, in this review, first, we introduce the drug carriers used in advanced nanotechnology and their strengths and limitations. Second, we provide an update on well-studied nanotechnology-based anticancer therapies related to the carcinogenesis process, including signaling pathways related to transforming growth factor-β (TGF-β), mitogen-activated protein kinase (MAPK), phosphatidylinositol 3 kinase (PI3K), Wnt, poly(ADP-ribose) polymerase (PARP), Notch, and Hedgehog (HH). Third, we introduce approved nanomedicines currently available for anticancer therapy. Fourth, we discuss the potential roles of natural phytochemicals as anticancer drugs. Fifth, we also discuss the synergistic effect of nanocarriers and phytochemicals in anticancer therapy.

4 May 2024 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
RIRezaul Islam
Rezaul Islam
Abdur RaufAbdur Rauf
Abdur Rauf
SAShopnil Alash
Shopnil Alash
NFNaeem Hossain Fakir
Naeem Hossain Fakir
GTGazi Kaifeara Thufa
Gazi Kaifeara Thufa
MTMuthu Thiruvengadam
Muthu Thiruvengadam

23 May 2024 in Plant Physiology and Biochemistry
Verified
Journal Article
Closed access
PKP. Saravana Kumari
P. Saravana Kumari
SRS. Ramkumar
S. Ramkumar
MSM. Seethalaxmi
M. Seethalaxmi
RTRekha Thiruvengadam
Rekha Thiruvengadam
MAM. Abiyoga
M. Abiyoga
SSS. Sureshkumar
S. Sureshkumar

1 October 2024 in Journal of microbiology, biotechnology and food sciences
Verified
Journal Article
Open access
PDF file
LNLakshmi Narayanan
Lakshmi Narayanan
DMDeepthi S Manisha
Deepthi S Manisha
AVAthira K V
Athira K V
SSSathianarayanan S
Sathianarayanan S
BVBaskar Venkidasamy
Baskar Venkidasamy
MSMohammad Ali Shariati
Mohammad Ali Shariati
Fruit wastes are one of the major sources of municipal waste, however they are a source of bioactive useful compounds which possess numerous health benefits. The fruit processing industry generates 10-60% waste or by-products in solid (peel, seed) and liquid (fruit juice) waste. Melon is a prevalent fruit, consumed worldwide, containing significant quantities of by-products (seed, peel, rind) that have been discarded. Melon is an excellent source of biologically active compounds for humans due to its good taste and rich chemical composition. Various bioactive compounds present in fruit waste (seed and rind) of melon is responsible for its numerous biological activities such as anti-inflammatory, antioxidant, anti-diabetic, anti-carcinogenic, and anti-microbial activity.